BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22660920)

  • 1. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.
    Noel G; Huchet A; Feuvret L; Maire JP; Verrelle P; Le Rhun E; Aumont M; Thillays F; Sunyach MP; Henzen C; Missohou F; de Crevoisier R; Bondiau PY; Collin P; Durando X; Truc G; Kerr C; Bernier V; Clavier JB; Atlani D; D'Hombres A; Vinchon-Petit S; Lagrange JL; Taillandier L
    J Neurooncol; 2012 Aug; 109(1):167-75. PubMed ID: 22660920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
    Noël G; Quetin P; Heymann S; Karamanoukian D; Schott R
    Cancer Radiother; 2009 Jan; 13(1):17-23. PubMed ID: 19091619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.
    Park CK; Lee SH; Kim TM; Choi SH; Park SH; Heo DS; Kim IH; Jung HW
    J Neurooncol; 2013 Apr; 112(2):277-83. PubMed ID: 23377829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.
    Niyazi M; Schwarz SB; Suchorska B; Belka C
    Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma management in the temozolomide era: have we improved outcome?
    Lwin Z; MacFadden D; Al-Zahrani A; Atenafu E; Miller BA; Sahgal A; Menard C; Laperriere N; Mason WP
    J Neurooncol; 2013 Nov; 115(2):303-10. PubMed ID: 23979682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma.
    Minniti G; De Sanctis V; Muni R; Rasio D; Lanzetta G; Bozzao A; Osti MF; Salvati M; Valeriani M; Cantore GP; Maurizi Enrici R
    J Neurooncol; 2009 Jan; 91(1):95-100. PubMed ID: 18758912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.
    Graus F; Bruna J; Pardo J; Escudero D; Vilas D; Barceló I; Brell M; Pascual C; Crespo JA; Erro E; García-Romero JC; Estela J; Martino J; García-Castaño A; Mata E; Lema M; Gelabert M; Fuentes R; Pérez P; Manzano A; Aguas J; Belenguer A; Simón A; Henríquez I; Murcia M; Vivanco R; Rojas-Marcos I; Muñoz-Carmona D; Navas I; de Andrés P; Mas G; Gil M; Verger E
    Neuro Oncol; 2013 Jun; 15(6):797-805. PubMed ID: 23460319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era.
    McNamara MG; Lwin Z; Jiang H; Chung C; Millar BA; Sahgal A; Laperriere N; Mason WP
    J Neurooncol; 2014 Mar; 117(1):153-60. PubMed ID: 24469855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
    Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
    Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
    J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
    Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
    Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
    Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Grossman SA; Ye X; Piantadosi S; Desideri S; Nabors LB; Rosenfeld M; Fisher J;
    Clin Cancer Res; 2010 Apr; 16(8):2443-9. PubMed ID: 20371685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
    Abrey LE
    Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility of the EORTC/NCIC Trial Protocol in a Neurosurgical Outpatient Unit: The Case for Neurosurgical Neuro-Oncology.
    Rapp M; Sadat H; Slotty PJ; Steiger HJ; Budach W; Sabel M
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):298-302. PubMed ID: 25915500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials.
    Balducci M; Fiorentino A; De Bonis P; Chiesa S; Mangiola A; Mattiucci GC; D'Agostino GR; Frascino V; Mantini G; Alitto AR; Colosimo C; Anile C; Valentini V
    Strahlenther Onkol; 2013 Nov; 189(11):926-31. PubMed ID: 23974823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery.
    Stummer W; Meinel T; Ewelt C; Martus P; Jakobs O; Felsberg J; Reifenberger G
    J Neurooncol; 2012 May; 108(1):89-97. PubMed ID: 22307805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.